There were 985 press releases posted in the last 24 hours and 425,053 in the last 365 days.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Events Leading to Termination of Senior Management

SAN FRANCISCO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys.

Visit: www.hbsslaw.com/investor-fraud/ofix
Contact An Attorney Now: OFIX@hbsslaw.com
                                                   844-916-0895

Orthofix Medical Inc. (OFIX) Investigation:

The investigation focuses on Orthofix’s recent assurances that “[i]t is our fundamental policy to conduct business in accordance with the highest ethical and legal standards.”

On Sept. 12, 2023, Orthofix abruptly terminated CEO Keith Valentine, CFO John Bostjancic, and Chief Legal Officer Patrick Keran “for cause.” The company explained that “the Board determined that each of these executives engaged in repeated inappropriate and offensive conduct that violated multiple code of conduct requirements and was inconsistent with the Company's values and culture.”

In response to this news, certain analysts downgraded Orthofix and the price of Orthofix sharply fell that day.

“We’re focused on investors’ losses and investigating whether Orthofix may have misled investors about its commitment to comply with its Ethics and Compliance program,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Orthofix Medical and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to frequently asked questions about the Orthofix investigation, read more »

Whistleblowers: Persons with non-public information regarding Orthofix Medical should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email OFIX@hbsslaw.com.

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices

Contact:
Reed Kathrein, 844-916-0895


Primary Logo